M1 Kliniken AG Stock
Your prediction
M1 Kliniken AG Stock
There is an upward development for M1 Kliniken AG compared to yesterday, with an increase of €0.32 (1.700%).
So far the community has only identified positive things for M1 Kliniken AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of M1 Kliniken AG in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of M1 Kliniken AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| M1 Kliniken AG | 1.700% | 0.946% | 3.672% | 43.928% | 0.000% | 144.275% | 92.000% |
| Mediclin AG | -3.290% | 3.865% | 8.040% | 43.333% | 20.112% | 41.447% | 6.436% |
| Vita 34 AG | -1.720% | -8.081% | -11.364% | -46.471% | -55.246% | -46.680% | -82.330% |
| Addus Homecare Corp. | 2.060% | -2.941% | 9.392% | 0.000% | 7.609% | 16.471% | 29.412% |
News
EQS-News: M1 Kliniken AG increases core “Beauty” business EBIT by 37.6% to EUR 9.2 million and completes strategic refocusing
EQS-News: M1 Kliniken AG increases core “Beauty” business EBIT by 37.6% to EUR 9.2 million and completes strategic refocusing
EQS-News: M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
EQS-News: M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
EQS-News: M1 Kliniken AG publishes annual report for 2025: strong growth in EBIT (+29%) and earnings per share (+40%)
EQS-News: M1 Kliniken AG publishes annual report for 2025: strong growth in EBIT (+29%) and earnings per share (+40%)